Pharmaceutical Artificial Intelligence - About the company
Pharmaceutical Artificial Intelligence is an unfunded company based in Bethesda (United States), founded in 2016. It operates as an AI-driven biotech accelerating drug discovery and development with generative AI. Pharmaceutical Artificial Intelligence has not raised any funding yet. The company has 179 active competitors, including 43 funded and 19 that have exited. Its top competitors include companies like Certara, Cartography Biosciences and TOLREMO therapeutics.
Company Details
AI-driven biotech accelerating drug discovery and development with generative AI. The company is a globally leading end-to-end generative AI-driven biotech, leveraging its proprietary Pharma.AI platform across biology, chemistry, and clinical development. Their generative AI platform helps rapidly and efficiently advance a fully self-generated AIDD pipeline primarily composed of novel drug candidates. They offer commercially-available end-to-end generative AI software and an automation platform designed to improve the quality and productivity of pharmaceutical research. The company utilizes large language models (LLLMs) in medicine and chemistry. They provide stand-alone technology access or combine their software with services for a data-driven AI-partnership. The company has a global presence and collaborates with industry partners, institutions, and universities on core AI projects. They focus on innovation, transparency, and patient-centric solutions.
Key Metrics
Founded Year
2016
Location
Bethesda, United States
Stage
Unfunded
Ranked
145th among 179 active competitors
Employee Count
284 as on Apr 30, 2026
Similar Companies
Legal entities associated with Pharmaceutical Artificial Intelligence
Pharmaceutical Artificial Intelligence is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PHARMACEUTICAL ARTIFICIAL INTELLIGENCE, INC. CIN: 5920761 , United States, Active | Dec 28, 2015 | - | - | - |
Sign up to download Pharmaceutical Artificial Intelligence's company profile
Pharmaceutical Artificial Intelligence's funding and investors
Pharmaceutical Artificial Intelligence has not raised any funding rounds yet.
Pharmaceutical Artificial Intelligence's founders and board of directors
Founder? Claim ProfilePharmaceutical Artificial Intelligence's employee count trend
Pharmaceutical Artificial Intelligence has 284 employees as of Apr 26. Here is Pharmaceutical Artificial Intelligence's employee count trend over the years:
Uncover Pharmaceutical Artificial Intelligence's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Pharmaceutical Artificial Intelligence's Competitors and alternates
Top competitors of Pharmaceutical Artificial Intelligence include Certara, Cartography Biosciences and TOLREMO therapeutics. Here is the list of Top 10 competitors of Pharmaceutical Artificial Intelligence, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Certara 2008, Princeton (United States), Public | Provider of a platform for in silico drug discovery and consulting services | - | 65/100 | |
2nd |  Cartography Biosciences 2020, Foster City (United States), Series B | Provider of a platform to discover immunotherapeutics | $124M | 63/100 | |
3rd |  TOLREMO therapeutics 2017, Zurich (Switzerland), Series A | Developing anti-cancer small molecules targeting novel drug resistance pathways | $55.8M | 60/100 | |
4th | Pharmacelera 2015, Barcelona (Spain), Series A | Hardware and software solutions for computer-aided drug design | $7.1M | 59/100 | |
5th | Oxford Drug Design 2001, Oxford (United Kingdom), Series A | Provider of computer-aided design of antibiotics for MDR infections | $12.4M | 58/100 | |
6th |  Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 58/100 | |
7th |  HotSpot Therapeutics 2017, Boston (United States), Series C | Developer of a platform for protein function analysis | $210M | 57/100 | |
8th |  Recludix Pharma 2020, San Diego (United States), Series A | Provider of the online platform for drug discovery and development | $60M | 57/100 | |
9th | Genialis 2015, Boston (United States), Series A | Developer of end-to-end bioinformatics software solutions | $16M | 56/100 | |
10th | AI-based precision medicine supporting tool for drug discovery | - | 55/100 | ||
145th | Pharmaceutical Artificial Intelligence 2016, Bethesda (United States), Unfunded | AI-driven biotech accelerating drug discovery and development with generative AI | - | - | 22/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Pharmaceutical Artificial Intelligence's competitors? Click here to see the top ones
Pharmaceutical Artificial Intelligence's Investments and acquisitions
Pharmaceutical Artificial Intelligence has made no investments or acquisitions yet.
News related to Pharmaceutical Artificial Intelligence
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Pharmaceutical Artificial Intelligence
Explore our recently published companies
- Theaiparagonconsulting - Unfunded company
- Thorncapstead Shop - Unfunded company
- Dashlexapro300 - Unfunded company
- Trysuperpower - Unfunded company
- Ashvamedhaai - Unfunded company
- Dzemat-Sabah - 2008 founded, Unfunded company
